Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Sign in
Welcome!
Log into your account
your username
your password
Forgot your password?
Password recovery
Recover your password
your email
Search
About
Advertise
Advisory Board
Contact Us
Sign in
Welcome! Log into your account
your username
your password
Forgot your password? Get help
Password recovery
Recover your password
your email
A password will be e-mailed to you.
Onco'Zine
Home
The War on Cancer
Cancer A – Z
Drug Approvals 2017
Articles
Conference Coverage
Editorial
Eric Rosenthal Reports
Expert Interview
Latest Articles
Publications
News
The Onco’Zine Brief
The Onco’Zine Brief Episodes
Upcoming Programs | Shows
How to Support The Onco’Zine Brief
Underwriting
The Onco’Zine Brief on PRX
The Onco’Zine Brief on Spreaker
Programs | Shows
Oncology Directory
Join Today
Event Agenda
Video
Home
Tags
DESTINY-Breast01 Trial
Tag: DESTINY-Breast01 Trial
Daiichi Sankyo Accelerates Biologics License Application for Trastuzumab Deruxtecan
Peter Hofland, Ph.D
-
March 29, 2019
LATEST
ASH 2019: Brentuximab Vedotin in Combination with Nivolumab in Frontline and R/R Hodgkin Lymphoma
Editorial Team
-
December 8, 2019
ASH 2019: Second-gen CAR T-Cell Therapy Overcome Resistance, Reduce Toxicity and Simplify Treatment
Peter Hofland, Ph.D
-
December 8, 2019
Addressing Disparities in Cancer: Factors Influencing Care, Access and Outcomes
Peter Hofland, Ph.D
-
December 8, 2019
